BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06504394-completion@plaintrial.com
DTSTAMP:20261028T061612Z
DTSTART;VALUE=DATE:20281108
SUMMARY:A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-34
 75) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants Wi
 th Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed o
 r Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-
 F65) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT06504394
URL:https://plaintrial.com/trial/NCT06504394
END:VEVENT
END:VCALENDAR